KLK6 and colorectal adenocarcinoma: Previous studies have reported that KLK6 mRNA has a clinical utility and a prognostic value, as a biomarker in colorectal adenocarcinoma since its expression in CRC correlated significantly with tumor stage and tumor grade and advanced Dukes’ stage, liver metastasis, and poor prognosis [18,19].